Expression level of pre-B-cell leukemia transcription factor 2 (PBX2) as a prognostic marker for gingival squamous cell carcinoma

Journal of Zhejiang University: Science B

Volumn 13, Issue 3, 2012, Pages 168-175

  Qiu, Ying ^a   Wang, Zhu Ling ^b   Jin, Shu Qing ^c   Pu, Yu Fei ^c   Toyosawa, Satoru ^d   Aozasa, Katsuyuki ^d   Morii, Eiichi ^d  

^a Tsinghua University   (China)

^b TONGJI UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

Gingival squamous cell carcinoma; Pre B cell leukemia transcription factor 2 (PBX2); Prognosis

Indexed keywords

PRE B CELL LEUKEMIA TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VALOSIN CONTAINING PROTEIN;

ADULT; AGED; ARTICLE; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENDOTHELIUM CELL; FEMALE; GINGIVA TUMOR; GINGIVAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADENOSINE TRIPHOSPHATASES; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL CYCLE PROTEINS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GINGIVAL NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

EID: 84863490719     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1100077     Document Type: Article

References (28)

1. Byers, R. M., White, D., Yue, A., 1981. Squamous carcinoma of the oral cavity: choice of therapy. Curr. Probl. Cancer, 6(5):1-27. [doi:10.1016/S0147- 0272 (81) 80015-3]
2. Cox, D. R., 1972. Regression models and life tables. J. Roy Stat. Soc., 34(3):187-220.
3. Eicher, S. A., Clayman, G. L., Liu, T. J., Shillitoe, E. J., Storthz, K. A., Roth, J. A., Lotan, R., 1996. Evaluation of topical gene therapy for head and neck squamous cell carcinoma in an organotypic model. Clin. Cancer Res., 2(10):1659-1664. (Pubitemid 26356348)
4. Gomez, D., Faucher, A., Picot, V., Siberchicot, F., Renaud-Salis, J. L., Bussières, E., Pinsolle, J., 2000. Outcome of squamous cell carcinoma of the gingiva: a follow-up study of 83 cases. J. Craniomaxillofac. Surg., 28(6):331-335. [doi:10.1054/jcms.2000.0177] (Pubitemid 32243891)
5. Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., Thun, M. J., 2003. Cancer statistics 2003. CA-Cancer J. Clin., 53(1):5-26. [doi:10.3322/canjclin. 53.1.5]
6. Kamps, M. P., Look, A. T., Baltimore, D., 1991. The human t (1; 19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev., 5(3):358-368. [doi:10.1101/gad.5.3.358] (Pubitemid 21905959)
7. Kaplan, E. L., Meier, P., 1958. Non-parametric estimation for incomplete observations. J. Am. Stat. Assoc., 53(282):457-481. [doi:10.2307/2281868]
8. Levi, P. A. Jr., Kim, D. M., Harsfield, S. L., Jacobson, E. R., 2005. Squamous cell carcinoma presenting as an endodontic-periodontic lesion. J. Periodontol., 76(10):1798-1804. [doi:10.1902/jop. 2005.76.10.1798] (Pubitemid 41645591)
9. Lippman, S. M., Hong, W. K., 2001. Molecular markers of the risk of oral cavity. N. Engl. J. Med., 344(17):1323-1326. [doi:10.1056/NEJM200104263441710] (Pubitemid 32372968)
10. Longobardi, E., Blasi, F., 2003. Overexpression of PREP-1 in F9 teratocarcinoma cells leads to a functionally relevant increase of PBX-2 by preventing its degradation. J. Biol. Chem., 278(40):39235-39241. [doi:10.1074/jbc. M304 704200] (Pubitemid 37221827)
11. Mann, R. S., Affolter, M., 1998. Hox proteins meet more partners. Curr. Opin. Genet. Dev., 8(4):423-429. [doi:10. 1016/S0959-437X (98) 80113-5] (Pubitemid 28412459)
12. Naora, H., Yang, Y. Q., Montz, F. J., Seidman, J. D., Kurman, R. J., Roden, R. B., 2001. A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells. PNAS, 98(7):4060-4065. [doi: 10.1073/pnas.071594398] (Pubitemid 32249898)
13. Phelan, M. L., Rambaldi, I., Featherstone, M. S., 1995. Cooperative interactions between Hox and Pbx proteins mediated by a conserved peptide motif. Mol. Cell Biol., 15(8):3989-3997.
14. Plowright, L., Harrington, K. J., Pandha, H. S., Morgan, R., 2009. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br. J. Cancer, 100(3):470-475. [doi:10.1038/sj.bjc.6604857]
15. Qiu, Y., Tomita, Y., Zhang, B. L., Nakamichi, I., Morii, E., Aozasa, K., 2007. Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth. Am. J. Pathol., 170(1):152-159. [doi:10.2353/ajpath.2007.060722] (Pubitemid 47339196)
16. Qiu, Y., Morii, E., Tomita, Y., Zhang, B. L., Matsumura, A., Kitaichi, M., Okumura, M., Aozasa, K., 2009. Prognostic significance of pre B cell leukemia transcription factor 2(PBX2) expression in non-small cell lung carcinoma. Cancer Sci., 100 (7):1198-1209. [doi:10.1111/j.1349-7006. 2009.01156.x]
17. Qiu, Y., Song, B., Zhao, G. F., Deng, B. Y., Makino, T., Tomita, Y., Wang, J. C., Luo, W. J., Doki, Y., Aozasa, K., et al., 2010. Expression level of pre B cell leukemia homeobox 2(PBX2) correlates with poor prognosis of gastric ade-nocarcinoma and esophageal squamous cell carcinoma. Int. J. Oncol., 36 (3):651-663. [doi:10.3892/ijo-00000541]
18. Randhawa, T., Shameena, P. M., Sudha, S., Nair, R. G., 2008. Squamous cell carcinoma of tongue in a 19-year-old female. Indian J. Cancer, 45(3):128-130. [doi:10.4103/0019-509X.44071]
19. Shaw, R. J., McGlashan, G., Woolgar, J. A., Lowe, D., Brown, J. S., Vaughan, E. D., Rogers, S. N., 2009. Prognostic importance of site in squamous cell carcinoma of the buccal mucosa. Br. J. Oral Maxillofac. Surg., 47(5):356-359. [doi:10.1016/j.bjoms.2008.09.017]
20. Sobin, L. H., Wittekind, C. H., 2002. TNM Classification of Malignant Tumours, 6th Ed. Wiley-Liss, New York, NY.
21. Soo, K. C., Spiro, R. H., King, W., Harvey, W., Strong, E. W., 1988. Squamous carcinoma of the gums. Am. J. Surg., 156(4):281-285. [doi:10.1016/S0002-9610 (88) 80292-7]
22. Takahashi, O., Hamada, J., Abe, M., Hata, S., Asano, T., Takahashi, Y., Tada, M., Miyamoto, M., Kondo, S., Moriuchi, T., 2007. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncol. Rep., 17(4):753-760.
23. van Dijk, M. A., Peltenburg, L. T., Murre, C., 1995. Hox gene products modulate the DNA binding activity of Pbx1 and Pbx2. Mech. Dev., 52(1):99-108. [doi:10.1016/0925-4773 (95) 00394-G]
24. Yamamoto, S., Tomita, Y., Hoshida, Y., Takiguchi, S., Fuji-wara, Y., Yasuda, T., Yano, M., Nakamori, S., Sakon, M., Monden, M., et al., 2003. Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J. Clin. Oncol., 21(13):2537-2544. [doi:10.1200/JCO.2003.12.102] (Pubitemid 46613487)
25. Yamamoto, S., Tomita, Y., Hoshida, Y., Toyosawa, S., Ino-hara, H., Kishino, M., Kogo, M., Nakazawa, M., Murakami, S., Iizuka, N., et al., 2004a. Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma. Ann. Oncol., 15(9):1432-1438. [doi:10.1093/annonc/mdh354] (Pubitemid 39295033)
26. Yamamoto, S., Tomita, Y., Hoshida, Y., Iizuka, N., Monden, M., Yamamoto, S., Iuchi, K., Aozasa, K., 2004b. Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma. Ann. Surg. Oncol., 11(7):697-704. [doi:10.1245/ASO.2004.10.018] (Pubitemid 40486705)
27. Yamamoto, S., Tomita, Y., Hoshida, Y., Iizuka, N., Kidogami, S., Miyata, H., Takiguchi, S., Fujiwara, Y., Yasuda, T., Yano, M., et al., 2004c. Expression level of valosin-containing protein (p97) is associated with prognosis of esophageal carcinoma. Clin. Cancer Res., 10(16):5558-5565. [doi:10.1158/1078- 0432. CCR-0723-03] (Pubitemid 39100496)
28. Yokoo, S., Umeda, M., Komatsubara, H., Shibuya, Y., Komori, T., 2002. Evaluation of T-classifications of upper gingival and hard palate carcinomas-a proposition for new criterion of T4. Oral Oncol., 38(4):378-382. [doi:10.1016/S1368-8375 (01) 00077-X] (Pubitemid 34655694)